Viewing Study NCT06627751


Ignite Creation Date: 2025-12-24 @ 11:46 PM
Ignite Modification Date: 2026-01-16 @ 7:16 PM
Study NCT ID: NCT06627751
Status: SUSPENDED
Last Update Posted: 2025-11-17
First Post: 2024-10-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Sponsor:
Organization: